Michelle Arkin is co-Director of the Small Molecule Discovery Center, Professor, and incoming department chair of Pharmaceutical Chemistry at UCSF. Her lab develops innovative approaches to screen for chemical tools and drug leads, using biophysical approaches like fragment-based drug discovery and biological approaches including high-content imaging. The lab’s goals are to demonstrate ‘druggability’ of new target classes for chemical biology and drug discovery. Areas of interest include protein-protein interactions, allosteric and scaffolding sites in enzymes, cancer and neurodegeneration.